Naimish Patel

Insider Reports History

Location
Boston, MA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Naimish Patel:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Medical Officer Common Shares 6,068 $218,083 $35.94 29 May 2025 Direct
CRISPR Therapeutics AG Chief Medical Officer Restricted Stock Units 25,000 30 May 2025 Direct
CRISPR Therapeutics AG Chief Medical Officer Stock Option (Right to Buy) 16,500 03 Oct 2025 Direct

Insider Reports Filed by Naimish Patel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRSP CRISPR Therapeutics AG 03 Oct 2025 1 $0 4 Chief Medical Officer 03 Oct 2025, 17:37
CRSP CRISPR Therapeutics AG 30 May 2025 1 $0 4 Chief Medical Officer 03 Jun 2025, 21:45
CRSP CRISPR Therapeutics AG 28 May 2025 3 -$141,316 4 Chief Medical Officer 30 May 2025, 17:00
CRSP CRISPR Therapeutics AG 14 Mar 2025 2 $0 4 Chief Medical Officer 18 Mar 2025, 17:35
CRSP CRISPR Therapeutics AG 16 Oct 2024 1 $0 4 Chief Medical Officer 18 Oct 2024, 17:35
CRSP CRISPR Therapeutics AG 28 May 2024 2 $0 4 Chief Medical Officer 29 May 2024, 16:15
CRSP CRISPR Therapeutics AG 28 May 2024 0 $0 3 Chief Medical Officer 28 May 2024, 16:14